Adverse Events Following Immunization (AEFI) of COVID-19 vaccines and their association with comorbidities in health personnel and public servants in Indonesia


health workers
public servants

How to Cite

Utami, W., Rahmawati, R., Patonah, S., & Wahyudi, I. (2022). Adverse Events Following Immunization (AEFI) of COVID-19 vaccines and their association with comorbidities in health personnel and public servants in Indonesia. Public Health of Indonesia, 8(2), 39–45.


Background: Health workers and public servants as the front line in service are prioritized to get the COVID-19 vaccination. The phenomenon of side effects is a major issue in administering the vaccination.

Objective: The research aimed to identify Adverse Events Following Immunization (AEFIs) and their correlation with comorbidities in health workers and public servants in Indonesia.

Methods: A cross-sectional study design was used in this study among 262 participants selected using purposive sampling. Data were collected using Google Form. Univariate analysis and Chi-Square were used for data analysis.

Results: Of all participants, 74.8% were not comorbid, and 25.2% were comorbid. The incidence of AEFI was 56.9%, relatively occurring after the vaccination I, II, and I and II. AEFI started 40.1% within 24 hours post-vaccination with a 48.7% symptom duration within 1-24 hours. AEFI reactions 42.3% are other reactions in the form of allergic reactions, drowsiness, and increased appetite. The Chi-Square test showed a p-value of 0.894, indicating that both comorbid and non-comorbid patients had the same risk of developing AEFI.

Conclusion: Comorbid or non-comorbid is safe to get COVID-19 vaccination. Supervisors reporting on AEFI is important to anticipate the severity condition. Health protocols must be implemented continually.


Ahmad, S., Singh, S., Wasim, S., & Rai, S. (2021). Adverse event following immunization (AEFI) and COVID-19 vaccination: A review. International Journal of Current Microbiology and Applied Sciences, 10, 555-565.

Anjorin, A. A., Abioye, A. I., Asowata, O. E., Soipe, A., Kazeem, M. I., Adesanya, I. O., . . . Omotayo, M. O. (2021). Comorbidities and the COVID-19 pandemic dynamics in Africa. Tropical Medicine and International Health, 26(1), 2-13.

Basavaraja, C. K., Sebastian, J., Ravi, M. D., & John, S. B. (2021). Adverse events following COVID-19 vaccination: First 90 days of experience from a tertiary care teaching hospital in South India. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211055833.

Budiono. (2016). Konsep dasar keperawatan. Jakarta: Bumi Medika.

Choi, W. S., & Cheong, H. J. (2021). COVID-19 vaccination for people with comorbidities. Infection & Chemotherapy, 53(1), 155-158.

Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W. C., Wang, C. B., & Bernardini, S. (2020). The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences, 57(6), 365-388.

Dinas Kesehatan Provinsi Jawa Timur. (2020). Profil kesehatan Provinsi Jawa Timur 2019. Jawa Timur: Dinas Kesehatan Provinsi Jawa Timur

Dinkes Kabupaten Bojonegoro. (2021a). Laporan vaksinasi Kabupaten Bojonegoro tahun 2020. Bojonegoro: Dinkes Kabupaten Bojonegoro

Dinkes Kabupaten Bojonegoro. (2021b). Profil kesehatan Kabupaten Bojonegoro tahun 2020. Bojonegoro: Dinkes Kabupaten Bojonegoro

Irnaningsih, I., Asriati, A., & Tosepu, R. (2021). COVID-19 preventive behavior of the community in Southeast Sulawesi Province, Indonesia. Public Health of Indonesia, 7(2), 87-92.

Jaiswal, K. M., Dudhgaonkar, S., Raghute, L., Uike, P., Kohli, S., & Anand, I. (2021). An assessment of AEFI COVID-19 vaccination in health care workers at a tertiary health care centre in central India. Microbiology Research International, 9, 46-50.

Josephine. (2020). Surveilans pemantauan Kejadian Ikutan Pasca Imunisasi (KIPI) Provinsi Jawa Timur. Jawa Timur: Surveilans KIPI Jatim

Joshi, R. K., Muralidharan, C. G., Gulati, D. S., Mopagar, V., Dev, J. K., Kuthe, S., . . . Sahoo, A. K. (2021). Higher incidence of reported adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine among previously infected health care workers. Medical Journal Armed Forces India, 77(Suppl 2), S505-s507.

Murti, B. (2003). Prinsip dan metode riset epidemiologi. Yogyakarta: Gadjah Mada University Press.

Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., . . . Mancia, G. (2008). European Society of Hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. Journal of Hypertension, 26(8), 1505-1526.

Rahayu, R. N. (2021). Vaksin COVID 19 di Indonesia: analisis berita hoax. Jurnal Ekonomi, Sosial & Humaniora, 2(07), 39-49.

Silva, R. B. D., Silva, T., Sato, A. P. S., Lana, F. C. F., Gusmão, J. D., Souza, J. F. A., & Matozinhos, F. P. (2021). Adverse events following immunization against SARS-CoV-2 (COVID-19) in the state of Minas Gerais. Revista de Saude Publica, 55, 66.

Srivastava, R., Ish, P., & COVID, S. (2021). The initial experience of COVID-19 vaccination from a tertiary care centre of India. Monaldi Archives for Chest Disease, 91(4).

Supangat, Sakinah, E. N., Nugraha, M. Y., Qodar, T. S., Mulyono, B. W., & Tohari, A. I. (2021). COVID-19 Vaccines Programs: Adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia. BMC Pharmacology and Toxicology, 22(1), 58.

Tosepu, R., Effendy, D. S., & Ahmad, L. (2020a). The first confirmed cases of COVID-19 in Indonesian citizens. Public Health of Indonesia, 6(2), 70-71.

Tosepu, R., Effendy, D. S., Lestari, H., Bahar, H., Asfian, P., & Sakka, A. (2020b). Vulnerability of weather on COVID-19 pandemic in West Java, Indonesia. Public Health of Indonesia, 6(4), 123-128.

Tosepu, R., Gunawan, J., Effendy, D. S., Ahmad, O. A. I., Lestari, H., Bahar, H., & Asfian, P. (2020c). Correlation between weather and COVID-19 pandemic in Jakarta, Indonesia. Science of the Total Enviromentn, 725, 138436.

World Health Organization. (2018). Causality assessment of an adverse event following immunization (AEFI): User manual for the revised WHO classification. Geneva: WHO.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2022 Wiwik Utami, Rahmawati, Siti Patonah, Imam Wahyudi


Download data is not yet available.